PayPal has proven a bad investment, and capital is better used in TransMedics and PROCEPT BioRobotics, whose valuations make no sense given how well their businesses are performing. Valuation models give PayPal about 40% upside versus over 100% for the other two, and no catalysts are in sight to take PayPal to $80. x.com x.com x.comÂ